...
首页> 外文期刊>British journal of ophthalmology >Injectable self inflating hydrogel pellet expanders for the treatment of orbital volume deficiency in congenital microphthalmos: preliminary results with a new therapeutic approach.
【24h】

Injectable self inflating hydrogel pellet expanders for the treatment of orbital volume deficiency in congenital microphthalmos: preliminary results with a new therapeutic approach.

机译:可注射的自膨胀水凝胶颗粒膨胀剂用于治疗先天性小眼球眼眶体积不足:采用新的治疗方法的初步结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND/AIM: Children with congenital microphthalmos are usually able to wear an eye prosthesis but the cosmetic aspect is determined by the size of the orbital volume deficiency. Instead of using a ball shaped standard hydrogel expander or a regular orbital implant, which would necessitate enucleation of the microphthalmic eye, this study investigates the feasibility of volume augmentation with injectable pellet expanders, as formerly suggested for acquired anophthalmos in adults only. METHOD: The pellet expander is made from a self inflating hydrogel that takes up water by osmosis (dry state: length 8 mm, diameter 2 mm, volume 0.025 ml; in vitro hydrated state after around 1 day: length 15 mm, diameter 4 mm, volume 0.24 ml; swelling capacity: 9.6-fold). This report concerns six patients (two girls and four boys) aged between 4 months and 42 months with unilateral microphthalmos who were treated by injection of 4-14 pellet expanders into the retrobulbar orbital tissue. Volume augmentation was 1-3.5ml. The pellets were injected using a customised trocar and placed behind the microphthalmos directed into the intraconal space. RESULTS: The increasing orbital volume was noticeable within 2 days and was confirmed by ultrasonography and magnetic resonance imaging. The final result can be anticipated by the volume augmentation effect produced by the amount of saline solution injected in the orbital apex region. All patients were fitted with an artificial eye, which was subsequently enlarged every 3-5 months. Anophthalmic enophthalmos was fully compensated with this technique. No complications have been encountered to date. CONCLUSIONS: Orbital volume augmentation with injectable self inflating hydrogel expander pellets is apparently a safe, quick, and minimally invasive technique for various indications in orbital reconstructive surgery-for example, to treat an enophthalmic appearance in microphthalmos and congenital or acquired anophthalmos.
机译:背景/目的:患有先天性小眼病的儿童通常能够佩戴眼假体,但外观方面是由眼眶体积不足的大小决定的。这项研究没有使用球形标准水凝胶膨胀剂或规则的眼眶植入物来摘除小眼科眼球,而是研究了可注射的颗粒状膨胀剂扩大容量的可行性,以前曾建议仅在成人中获得性眼球扩大剂。方法:颗粒膨胀剂由自膨胀水凝胶制成,该水凝胶通过渗透作用吸收水分(干燥状态:长8 mm,直径2 mm,体积0.025 ml;约1天后的体外水合状态:长15 mm,直径4 mm ,体积为0.24毫升;溶胀容量:9.6倍。该报告涉及6例年龄在4个月至42个月之间的单眼小眼病患者(两个女孩和四个男孩),他们通过向球后眼眶组织注射4-14个球囊扩张器进行治疗。体积增加为1-3.5ml。使用定制的套管针注射小球,并将小球置于定向到圆锥内腔的小眼后方。结果:在2天内,眼眶体积增加明显,并且通过超声检查和磁共振成像证实。可以通过注射到眼眶顶点区域的盐溶液量产生的体积增加效应来预期最终结果。所有患者均配有假眼,随后每3-5个月扩大一次。这种技术可以完全弥补无眼性眼病。迄今为止尚未遇到并发症。结论:可注射的自膨胀水凝胶膨胀剂药丸增加眼眶容积显然是一种安全,快速,微创的技术,可用于眼眶重建手术中的各种适应症,例如,治疗微眼球和先天性或获得性无眼症的眼睑外观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号